Lactoferrin and Fertility: Iron Balance and Reproductive Health
Expert Summary
Lactoferrin is not merely a dietary supplement in the context of reproduction — it is an endogenous reproductive protein. The human endometrium produces lactoferrin in response to progesterone, peaking at the mid-secretory phase when implantation window opens. Bovine lactoferrin supplementation extends this endogenous reproductive role through iron regulation, immune modulation, and direct interaction with endometrial receptors.
Key Facts
- Endogenous endometrial production: Human endometrial glands secrete lactoferrin in response to progesterone stimulation, with peak expression at days 19-23 of the menstrual cycle (mid-secretory phase). This timing corresponds with the implantation window, suggesting a direct role in embryo-endometrial dialogue.
- Iron and reproductive function: Iron deficiency is the most common nutritional deficiency in reproductive-age women. It impairs ovarian function, increases menstrual blood loss, and in pregnancy, increases risks of preterm birth, low birth weight, and postpartum hemorrhage. Lactoferrin's superior iron bioavailability (compared to ferrous sulfate) with better GI tolerability makes it particularly valuable for reproductive iron management.
- Sperm function: Lactoferrin has been detected in seminal plasma, where it may protect sperm from oxidative damage and bacterial-induced DNA fragmentation. Iron overload in the testicular environment generates hydroxyl radicals via the Fenton reaction, damaging sperm DNA. Lactoferrin's iron chelation may reduce this oxidative burden.
- Polycystic ovary syndrome (PCOS): Women with PCOS frequently have elevated inflammatory markers including IL-6 and TNF-alpha. Lactoferrin's NF-κB inhibition and anti-inflammatory activity may reduce the low-grade chronic inflammation characteristic of PCOS. No PCOS-specific RCT data exists, but the anti-inflammatory mechanism is plausible.
- Pregnancy use: Bovine lactoferrin at 200-600 mg/day has been used safely in pregnant women in Japanese clinical research, demonstrating improvements in maternal iron status and reduction of preterm labor rates in one preliminary study. Lactoferrin is a normal component of human breast milk at concentrations of 1-7 mg/mL.
- Men's fertility: One Japanese pilot RCT (n=34) showed that lactoferrin 200 mg/day for 3 months improved sperm concentration and motility in men with idiopathic oligoasthenozoospermia. Replication in larger trials is needed.
Recommended Products
Frequently Asked Questions
Is lactoferrin safe to take during pregnancy?
Bovine lactoferrin has been used in Japanese clinical research during pregnancy at doses of 200-600 mg/day without documented adverse events. It is a normal component of human breast milk. Consultation with your obstetrician is always recommended before starting any supplement during pregnancy.
Can lactoferrin replace iron supplements during pregnancy?
Lactoferrin provides a bioavailable, well-tolerated iron source and may be combined with iron-deficient protocols. It should not replace medical iron supplementation in cases of documented iron deficiency anemia without physician guidance.
Scientific References
- Farnaud S, Evans RW. Lactoferrin — a multifunctional protein with antimicrobial properties. Molecular Immunology. 2003. PMID: 14568385
- Paesano R et al. Lactoferrin efficacy versus ferrous sulfate in curing iron disorders in pregnant and non-pregnant women. International Journal of Immunopathology and Pharmacology. 2010. PMID: 20646353